GSA CAPITAL PARTNERS LLP - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 38 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$341,000
-43.5%
56,673
-16.9%
0.04%
-30.6%
Q3 2021$604,000
+61.9%
68,205
+44.8%
0.06%
+47.6%
Q2 2021$373,000
+25.6%
47,097
+20.7%
0.04%
-14.3%
Q1 2021$297,000
+121.6%
39,006
+182.2%
0.05%
+122.7%
Q3 2020$134,00013,8230.02%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Interchange Capital Partners, LLC 11,420$90,0000.14%
GSA CAPITAL PARTNERS LLP 47,097$373,0000.04%
GOODWIN DANIEL L 10,000$80,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 99,166$784,0000.01%
EMFO, LLC 1,666$13,0000.01%
PINNACLE ASSOCIATES LTD 34,333$272,0000.01%
BLAIR WILLIAM & CO/IL 51,466$407,0000.00%
Tarbox Family Office, Inc. 332$3,0000.00%
Hartford Financial Management Inc. 598$5,0000.00%
Tower Research Capital LLC (TRC) 3,808$30,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders